List of Tables
Table 1. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Trends
Table 2. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Drivers & Opportunity
Table 3. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Challenges
Table 4. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Restraints
Table 5. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Chimeric Antigen Receptor (CAR)-T Cell Therapy Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Chimeric Antigen Receptor (CAR)-T Cell Therapy Product Type
Table 9. Key Companies Time to Begin Mass Production of Chimeric Antigen Receptor (CAR)-T Cell Therapy
Table 10. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Region (2019-2024) & (%)
Table 27. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value, (2025-2030) & (US$ Million)
Table 31. Autolus Therapeutics Basic Information List
Table 32. Autolus Therapeutics Description and Business Overview
Table 33. Autolus Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Products, Services and Solutions
Table 34. Revenue (US$ Million) in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business of Autolus Therapeutics (2019-2024)
Table 35. Autolus Therapeutics Recent Developments
Table 36. CARsgen Therapeutics Basic Information List
Table 37. CARsgen Therapeutics Description and Business Overview
Table 38. CARsgen Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Products, Services and Solutions
Table 39. Revenue (US$ Million) in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business of CARsgen Therapeutics (2019-2024)
Table 40. CARsgen Therapeutics Recent Developments
Table 41. Juno Therapeutics Basic Information List
Table 42. Juno Therapeutics Description and Business Overview
Table 43. Juno Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Products, Services and Solutions
Table 44. Revenue (US$ Million) in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business of Juno Therapeutics (2019-2024)
Table 45. Juno Therapeutics Recent Developments
Table 46. Sorrento Therapeutics Basic Information List
Table 47. Sorrento Therapeutics Description and Business Overview
Table 48. Sorrento Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Products, Services and Solutions
Table 49. Revenue (US$ Million) in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business of Sorrento Therapeutics (2019-2024)
Table 50. Sorrento Therapeutics Recent Developments
Table 51. bluebird bio Basic Information List
Table 52. bluebird bio Description and Business Overview
Table 53. bluebird bio Chimeric Antigen Receptor (CAR)-T Cell Therapy Products, Services and Solutions
Table 54. Revenue (US$ Million) in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business of bluebird bio (2019-2024)
Table 55. bluebird bio Recent Developments
Table 56. CELGENE CORPORATION Basic Information List
Table 57. CELGENE CORPORATION Description and Business Overview
Table 58. CELGENE CORPORATION Chimeric Antigen Receptor (CAR)-T Cell Therapy Products, Services and Solutions
Table 59. Revenue (US$ Million) in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business of CELGENE CORPORATION (2019-2024)
Table 60. CELGENE CORPORATION Recent Developments
Table 61. Eureka Therapeutics Basic Information List
Table 62. Eureka Therapeutics Description and Business Overview
Table 63. Eureka Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Products, Services and Solutions
Table 64. Revenue (US$ Million) in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business of Eureka Therapeutics (2019-2024)
Table 65. Eureka Therapeutics Recent Developments
Table 66. Avacta Life Sciences Basic Information List
Table 67. Avacta Life Sciences Description and Business Overview
Table 68. Avacta Life Sciences Chimeric Antigen Receptor (CAR)-T Cell Therapy Products, Services and Solutions
Table 69. Revenue (US$ Million) in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business of Avacta Life Sciences (2019-2024)
Table 70. Avacta Life Sciences Recent Developments
Table 71. Calyxt Basic Information List
Table 72. Calyxt Description and Business Overview
Table 73. Calyxt Chimeric Antigen Receptor (CAR)-T Cell Therapy Products, Services and Solutions
Table 74. Revenue (US$ Million) in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business of Calyxt (2019-2024)
Table 75. Calyxt Recent Developments
Table 76. Celyad Oncology SA Basic Information List
Table 77. Celyad Oncology SA Description and Business Overview
Table 78. Celyad Oncology SA Chimeric Antigen Receptor (CAR)-T Cell Therapy Products, Services and Solutions
Table 79. Revenue (US$ Million) in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business of Celyad Oncology SA (2019-2024)
Table 80. Celyad Oncology SA Recent Developments
Table 81. Fortress Biotech Basic Information List
Table 82. Fortress Biotech Description and Business Overview
Table 83. Fortress Biotech Chimeric Antigen Receptor (CAR)-T Cell Therapy Products, Services and Solutions
Table 84. Revenue (US$ Million) in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business of Fortress Biotech (2019-2024)
Table 85. Fortress Biotech Recent Developments
Table 86. IMMUNE THERAPEUTICS Basic Information List
Table 87. IMMUNE THERAPEUTICS Description and Business Overview
Table 88. IMMUNE THERAPEUTICS Chimeric Antigen Receptor (CAR)-T Cell Therapy Products, Services and Solutions
Table 89. Revenue (US$ Million) in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business of IMMUNE THERAPEUTICS (2019-2024)
Table 90. IMMUNE THERAPEUTICS Recent Developments
Table 91. Gilead Sciences Basic Information List
Table 92. Gilead Sciences Description and Business Overview
Table 93. Gilead Sciences Chimeric Antigen Receptor (CAR)-T Cell Therapy Products, Services and Solutions
Table 94. Revenue (US$ Million) in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business of Gilead Sciences (2019-2024)
Table 95. Gilead Sciences Recent Developments
Table 96. Novartis AG Basic Information List
Table 97. Novartis AG Description and Business Overview
Table 98. Novartis AG Chimeric Antigen Receptor (CAR)-T Cell Therapy Products, Services and Solutions
Table 99. Revenue (US$ Million) in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business of Novartis AG (2019-2024)
Table 100. Novartis AG Recent Developments
Table 101. Alaunos Therapeutics Basic Information List
Table 102. Alaunos Therapeutics Description and Business Overview
Table 103. Alaunos Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Products, Services and Solutions
Table 104. Revenue (US$ Million) in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business of Alaunos Therapeutics (2019-2024)
Table 105. Alaunos Therapeutics Recent Developments
Table 106. Poseida Therapeutics Basic Information List
Table 107. Poseida Therapeutics Description and Business Overview
Table 108. Poseida Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Products, Services and Solutions
Table 109. Revenue (US$ Million) in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business of Poseida Therapeutics (2019-2024)
Table 110. Poseida Therapeutics Recent Developments
Table 111. Key Raw Materials Lists
Table 112. Raw Materials Key Suppliers Lists
Table 113. Chimeric Antigen Receptor (CAR)-T Cell Therapy Downstream Customers
Table 114. Chimeric Antigen Receptor (CAR)-T Cell Therapy Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Chimeric Antigen Receptor (CAR)-T Cell Therapy Product Picture
Figure 2. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value (2019-2030) & (US$ Million)
Figure 4. Chimeric Antigen Receptor (CAR)-T Cell Therapy Report Years Considered
Figure 5. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue in 2023
Figure 7. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Abecma Picture
Figure 9. Breyanzi Picture
Figure 10. Kymriah Picture
Figure 11. Tecartus Picture
Figure 12. Yescarta Picture
Figure 13. Others Picture
Figure 14. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value Market Share by Type, 2023 & 2030
Figure 16. Product Picture of Hospital
Figure 17. Product Picture of Diagnostic Center
Figure 18. Product Picture of Other
Figure 19. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value (%), (2019-2030)
Figure 32. United States Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 38. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 40. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 50. India Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 52. India Chimeric Antigen Receptor (CAR)-T Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 53. Chimeric Antigen Receptor (CAR)-T Cell Therapy Industrial Chain
Figure 54. Chimeric Antigen Receptor (CAR)-T Cell Therapy Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
